Skip to content

Effect of Sevoflurane on Sweat Threshold in Children of Different Ages

Effect of Sevoflurane on Sweat Threshold in Children of Different Ages

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07035782
Enrollment
100
Registered
2025-06-25
Start date
2025-06-30
Completion date
2026-06-30
Last updated
2025-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Only, Low Body Temperatures, Sevoflurane, Temperature Regulation; Disorder

Keywords

Pediatric Anesthesia, Low Body Temperatures, Sevoflurane

Brief summary

Hypothermia is a common complication in pediatric anesthesia. Hypothermia will prolong the recovery time of anesthesia, and may also lead to increased oxygen consumption, prolonged blood coagulation time, and affect the metabolism of anesthetic drugs and postoperative immune function. Sevoflurane is the most commonly used inhaled anesthetic in children. This study explored the effect of sevoflurane on the sweat threshold of pediatric patients and analyzed the characteristics of body temperature regulation in children of different ages under anesthesia, which will help to understand the mechanism of body temperature regulation in children under anesthesia, and also provide a scientific basis for clinical anesthesia temperature management.

Detailed description

Standardized anesthesia induction was used for all participants. The first step was mask oxygen inhalation under 5 L/min pure oxygen, and 8% sevoflurane was inhaled for induction. Once the child lost consciousness, the concentration of sevoflurane was reduced to 3%-5% and maintained at 1.2 MAC as much as possible. Tracheal intubation was then assisted with cisatracurium 0.2 mg/kg. Mechanical ventilation was maintained during the operation, and the end-tidal carbon dioxide level was monitored and maintained at about 35 mmHg. Caudal anesthesia with 0.25% ropivacaine was used to provide surgical site analgesia. TOF was performed throughout the procedure to monitor the depth of neuromuscular block. Core temperature was measured in the distal esophagus. The esophageal probe was inserted after intubation to a depth of one quarter of the patient's height plus 4.5 cm. Changes in surface humidity were monitored using an OM-62 humidity sensor, which was placed above the nipple line in the upper chest and suspended in the ostomy bag. The ostomy bag will be custom-cut as needed to ensure optimal fit and precise airflow control. Infants and young children (\<6 years) will use a 4-cm diameter opening, while older children (6 to 12 years) will use a 6-cm diameter opening. To ensure smooth airflow in the stoma bag, a low flow meter will be used to accurately adjust the airflow rate to 0.5L/min. Skin water loss (in g/m²/h) will be calculated from airflow rate, temperature, and relative humidity, and sweating on the child's forehead will be observed and recorded every 3 minutes. The skin surface was wrapped with a plastic film to limit evaporation. An air mattress was used to cover the body up to the nipple line. Two disposable covers were placed on each chest and leg and connected to an inflatable heating device, respectively. The inflatable heating device was set to 43 ° C until the esophageal temperature reached 38 ° C. Core temperature as well as temperature and humidity in the ostomy bag were collected every minute. The Hotline system was used to warm the intravenous infusion. Once the patient's core temperature reached 38 ° C or the procedure was over, active warming was stopped. Heart rate and pulse oxygen saturation were continuously monitored, and blood pressure was measured every 3 minutes. Simulated data from the heart rate monitor, sweat sensor, respiratory gas monitor, and pulse oximeter were recorded at 3-min intervals using the data acquisition system described above. The end-expiratory anesthetic concentration during the whole procedure was also recorded.

Interventions

Core temperature will be measured in the distal esophagus. The esophageal probe will be inserted after intubation to the depth from the upper incisors recommended by Bloch et al,1 specifically one-quarter of the patient's height plus 4.5 cm.

DRUGSevoflurane

Anesthesia induction will be standardized for all participants., the children will undergo inhalational induction using 8% sevoflurane with a fresh gas flow of 5 L/min in 100% oxygen. Once children loses consciousness, the sevoflurane concentration will be reduced to 3%-5% and then maintained as close as possible to 1.2 MAC, age-adjusted

Sponsors

Second Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: 0-12 years old; 2. American Society of Anesthesiologists physical status I or II; 3. Weight within the normal range and body-mass index (BMI) for age between the 25th and 85th percentiles; 4. scheduled elective lower-body surgery under general anesthesia, expected to last at least 1 hour.

Exclusion criteria

1. The guardian of the child refused to participate in the study; 2. Operations involving extensive incisions, such as massive debridement or other operations requiring removal of large amounts of tissue; 3. Contraindications to esophageal temperature probe insertion (e.g., esophageal varices, congenital anomalies); 4. Thyroid dysfunction or autonomic dysfunction; 5. Premature infants (≤1 year old).

Design outcomes

Primary

MeasureTime frameDescription
The threshold esophageal temperatureDuring the operationThe threshold esophageal temperature at which forehead sweating is first observed (any sustained increase in cutaneous water loss).

Secondary

MeasureTime frameDescription
The gain of sweatingDuring the operationthe slope of the core temperature versus quantitative sweating rate from onset of sweating until the maximum is reached
Maximum sweating rateDuring the operationas indicated by no further increase in sweat rate despite further increase in core temperature

Countries

China

Contacts

Primary ContactHuacheng Liu
huachengliu@163.com13957770577
Backup ContactYuhang Cai
838097626@qq.com18815091585

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026